The California Institute for Regenerative Medicine has awarded UC San Diego researchers $4.8 million to advance a gene therapy to treat Friedreich’s ataxia, a rare but devastating neuromuscular disorder.
Scientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ Disease
